The Science Behind Extrasensory Perception(esp): Exploring the Unseen Kumar Jeetendra | September 5, 2023 Extrasensory perception (ESP) is perception that occurs in addition to or instead of the recognized sensory systems. This group of phenomena often includes telepathy, or the transmission of thoughts between individuals, clairvoyance, or the paranormal awareness of objects or occurrences not necessarily known to others, and precognition, or knowledge of the future. The scientific research …
Cipla launches CIPLAMED 2.0 – knowledge-sharing platform for Healthcare Practitioners (HCPS) Kumar Jeetendra | August 16, 2023 Mumbai, India; 16th August 2023: Cipla announced the launch of CiplaMed 2.0, an enhanced version of the industry-leading knowledge platform for the medical fraternity. In line with its digital transformation agenda, Cipla is pioneering an integrated omnichannel experience for healthcare professionals that seamlessly combines in-clinic interactions with digital engagement and access to medical information. This …
The weather woman of India: Anna Mani Kumar Jeetendra | August 3, 2023 Anna Mani was a distinguished physicist and meteorologist who worked in India. Anna Mani made a number of significant contributions to the field of meteorology and weather sciences in India. Here are some key points about anna mani: Early Life and Education of Anna Mani: Anna Mani’s birthday is August 23rd, and she was born …
Stock in Gland Pharma soars 5% after the US FDA makes no adverse findings Kumar Jeetendra | July 31, 2023 After receiving a zero-observation certificate from the US drug agency for its Visakhapatnam facility, Gland Pharma’s share price increased by 5.49 percent, closing at Rs 1,365 at 9:23am on July 31. Between July 20 and July 28, the United States Food and Drug Administration (US FDA) inspected the company’s VSEZ Sterile Oncology plant in Visakhapatnam …
Cipla tops BW India’s Most Sustainable Companies Rankings for 2022-23 Kumar Jeetendra | June 30, 2023 Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has been ranked 1st in the Pharmaceuticals & Healthcare Sector and 5th in the Top 50 Most Sustainable Companies at the 3rd edition of BW India’s Most Sustainable Companies Awards 2022-23. This recognition acknowledges Cipla’s efforts in the …
Dr. Reddy’s enters the trade generics business in India Kumar Jeetendra | June 23, 2023 Hyderabad, India; June 23, 2023 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a global pharmaceutical company, today announced its entry into the trade generics business in India with the launch of its new dedicated division ‘RGenX’. Through this, Dr. Reddy’s aims to provide …
IOL Chemicals and Pharmaceuticals Receives CEP for Paracetamol to Export in European Market Kumar Jeetendra | May 8, 2023 IOL Chemicals and Pharmaceuticals Limited (IOL), a leading manufacturer of pharmaceutical (APIs) and specialty chemicals, has received the European Directorate for the Quality of Medicines & HealthCare’s (EDQM) Certificate of Suitability (CEP) to export Paracetamol to the European Market. Paracetamol is utilised commonly in medication prescribed for pain relief and to treat fever. The certification …
Israeli researchers develop an effective drug to prevent muscle diseases Kumar Jeetendra | April 4, 2023 Statins are the most commonly used medication in lowering blood cholesterol, prescribed to tens of millions in the Western world. Statins act through inhibition of the enzyme HMG CoA reductase. Nearly 20% of statin users develop muscle symptoms (“statin myopathy”) including weakness and pain. In about 1%, this myopathy is severe and does not subside …
Alembic Pharma announces Brimonidine Tartrate Ophthalmic Solution USFDA Final Clearance Kumar Jeetendra | March 31, 2023 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Brimonidine Tartrate Ophthalmic Solution, 0.15%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Alphagan P Ophthalmic Solution, 0.15%, of AbbVie Inc. Brimonidine Tartrate …
Definition, types, and parameters affecting effective synthesis reactions Kumar Jeetendra | March 13, 2023 The synthesis reaction is the process of combining two chemicals to form a new one. As we’ll see in a bit with photosynthesis, synthesis reactions don’t always produce just one product. Whether it results in a single complicated product or several simpler ones, the phrase “combination” is an excellent mental shorthand for a synthesis reaction. …
Alembic Pharma announces Brexpiprazole tablets USFDA Tentative Approval Kumar Jeetendra | March 10, 2023 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), …
Soft gelatine capsule temperature regulation: All you need to know Kumar Jeetendra | March 10, 2023 A solid oral dosage form, capsules are used for the delivery of life-saving medications, minerals, vitamins, and other healthful elements that are found in dietary supplements. These user-friendly containers make accurate dosing, mobility, and a high degree of consumer compliance possible. Other options include formulations that are more difficult to transport, such as liquid, powder, …
